September 26th 2025
Facilitating increased efficiency in radiation therapy planning, the new Rembra RT and Areta RT computed tomography platforms reportedly offer 4D CT capabilities and image reconstruction speeds up to 106 images per second.
ScanLab Unveils New Signal-to-Noise Ratio (SNR) Calculator for MRI
September 16th 2025Offering prospective SNR calculation derived from prescribed slices, the SNR Calculator reportedly facilitates a higher degree of accuracy with quantitative SNR values beyond that of calculators from device manufacturers.
Multicenter Study Finds Abbreviated MRI Non-Inferior to mpMRI for csPCa Detection
September 11th 2025Abbreviated biparametric MRI demonstrated nearly equivalent detection rates for clinically significant and clinically insignificant prostate cancer as multiparametric MRI, according to research involving 22 centers in 12 countries.
Could A Specificity Emphasis for MRI-Based T-Staging Reinvent Staging for Prostate Cancer?
August 18th 2025In a new review of MRI-based scoring systems for T-staging of prostate cancer, researchers discuss key literature findings and principles in evaluating the extent of prostate cancer (PCa) lesions, and whether a focus on specificity could enhance the staging of PCa.
Can Multimodal AI Enhance Prediction of Biochemical Recurrence After Prostatectomy?
August 8th 2025A deep learning multimodal model that incorporates MRI features offered nearly double the sensitivity for predicting post-prostatectomy biochemical recurrence of prostate cancer in comparison to the traditional CAPRA-S scoring system.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
July 31st 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.